Role of Intravenous Calcium to Decrease Blood Loss During Intrapartum Cesarean Section

Starting soon · Phase 2 · Has a placebo group

Conditions studied: Post Partum Haemorrhage, Cesarean Section Surgery

In brief

To determine the effectiveness of prophylactic intravenous calcium chloride administered after cord clamping in reducing postpartum blood loss during intrapartum cesarean section.

Key facts

Study ID

NCT07550413

Run by

Pak Emirates Military Hospital

People needed

182

Starts

2026-05-01

Expected to finish

2026-12-01

Last updated by the study team

2026-04-24

Who can join

Age: 18 and older, up to 45. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Women aged 18-45 years undergoing intrapartum cesarean section at ≥34 weeks of gestation.
• Exposure to oxytocin during labor before CS.
• Singleton pregnancy with no known fetal anomalies.

You may not qualify if…

• Known bleeding disorders or preoperative coagulation abnormalities
• Preeclampsia or hypertensive disorders contraindicate calcium use.
• History of cardiac disease or arrhythmias
• Placental abnormalities, i.e., placenta previa, accreta
• Emergency CS with fetal distress or cord prolapse.
• Known hypersensitivity to calcium chloride.

Where it is running

• Pak Emirates Military Hospital — Rawalpindi, Punjab Province, Pakistan

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.